Table 1.
Demographics of a cohort of individuals with cytologically benign (Bethesda II) nodules (for individuals with Thyroid Imaging, Reporting and Data System 5 nodules, for individuals with Thyroid Imaging, Reporting and Data System <5 nodules, and for all individuals)
| TI-RADS 5 Bethesda II (n = 33) | TI-RADS <5 Bethesda II (n = 563) | Total (n = 596) | |
|---|---|---|---|
| Sex | |||
| Female | 29 (88) | 441 (78) | 470 (79) |
| Male | 4 (12) | 122 (22) | 126 (21) |
| Age (years), mean (range) | |||
| 58.5 (29–85) | 56 (17–90) | 56.2 (17–90) | |
| Indication(s) for procedure | |||
| Compression | 19 (58) | 431 (77) | 450 (76) |
| Growth | 0 | 7 (1) | 7 (1.2) |
| Risk of malignancy | 10 (30) | 68 (12) | 78 (13) |
| Single nodule (non-toxic) | 0 | 4 (0.7) | 4 (0.7) |
| Multi-nodular goitre (non-toxic) | 0 | 5 (0.9) | 5 (0.8) |
| Retrosternal goitre | 6 (18) | 69 (12) | 75 (13) |
| Single nodule (toxic) | 0 | 2 (0.4) | 2 (0.3) |
| Multi-nodular goitre (toxic) | 1 (3.0) | 25 (4.4) | 26 (4.4) |
| Graves’ disease | 0 | 4 (0.7) | 4 (0.7) |
| Other | 0 | 10 (1.8) | 10 (1.7) |
| Procedure performed | |||
| Total thyroidectomy | 14 (44) | 223 (40) | 237 (40) |
| Hemithyroidectomy | 19 (58) | 325 (58) | 344 (58) |
| Nodulectomy | 0 | 6 (1.1) | 6 (1) |
| Other | 0 | 9 (1.5) | 9 (1.5) |
| Histopathology | |||
| Benign | 22 (67) | 556 (99) | 578 (97) |
| Malignant | 11 (33) | 7 (1.2) | 18 (3.0) |
Values are n (%) unless otherwise indicated. TI-RADS, Thyroid Imaging, Reporting and Data System.